How tirzepatide's action on two hormone receptors drives weight loss

Step 1: the injection, and what happens in the first few hours

Each Mounjaro pen delivers a measured dose of tirzepatide into the fatty tissue just beneath the skin, typically the abdomen, thigh, or upper arm. From there it moves into the bloodstream gradually, which is why the medicine is taken just once a week rather than daily. The pen itself is a pre-filled KwikPen; once your order arrives with DPD in plain packaging, you'll find a clear labelled box with the pen inside, ready to use. Within hours of injection, tirzepatide begins binding to GIP and GLP-1 receptors across several tissues, including the pancreas, gut, and brain, a process explained in detail on our Mounjaro action page.

GIP stands for glucose-dependent insulinotropic polypeptide, and GLP-1 for glucagon-like peptide-1. Both are hormones the gut releases naturally after a meal. Tirzepatide mimics and extends their signals, keeping the satiety message running well beyond what a normal meal would trigger. The NHS tirzepatide medicines page explains this dual mechanism in patient-friendly terms.

Step 2: appetite suppression and the slowing of gastric emptying

One of the most immediate effects people notice is a reduced drive to eat. Tirzepatide acts on appetite-regulating centres in the brain, so portions that once felt small start to feel sufficient. Alongside this, gastric emptying slows: food moves through the stomach more slowly, keeping you fuller for longer after each meal. Together these two effects tend to reduce total calorie intake without requiring the constant conscious effort that dieting alone demands.

The GIP component adds something the GLP-1 pathway alone does not offer. Research suggests GIP receptor activation amplifies the appetite-suppressing effect and may also influence how the body stores and releases fat. This is why tirzepatide's dual-receptor mechanism produced larger average weight reductions in clinical trials than earlier single-pathway medicines. In the SURMOUNT-1 trial, thousands of adults without diabetes lost an average of around 20–21% of body weight over 72 weeks at the highest dose, figures cited in NICE's appraisal of tirzepatide (TA1026).

Step 3: the titration schedule and why the starter dose is not the treatment dose

Tirzepatide treatment opens at 2.5 mg, a dose chosen for tolerability rather than therapeutic effect. The gut needs several weeks to settle into the new hormonal signals before the dose steps up. Nausea, the side effect people most often ask about, is most likely during the early weeks and after each increase; starting low keeps this manageable for most people. The prescriber then titrates upward in roughly four-week steps, through 5, 7.5, 10, 12.5, and up to 15 mg, guided by how the patient is responding.

Dose increases aren't automatic. A prescriber reviews your progress before each step, which is why understanding when tirzepatide begins to work matters as much as understanding the mechanism itself. If you're thinking about what private treatment involves, the cost of Mounjaro in the UK and what a legitimate price covers are worth reading alongside this page. For the exact storage windows, missed-dose guidance, and contraindications, always refer to the Patient Information Leaflet supplied with your pen or the Mounjaro SmPC on the electronic Medicines Compendium.

Step 4: how the action changes over weeks of treatment

The weight-loss effect of tirzepatide is not instant, and understanding this helps set realistic expectations. The first few weeks are largely about adjustment, the body learning the new hormonal rhythm. Appetite suppression deepens as the dose increases. Most people find the rate of weight change accelerates in the middle months of treatment, then gradually plateaus as the body reaches a new equilibrium. Clinical trials followed participants for 72 weeks, and the largest weight reductions were seen at the higher doses after sustained treatment.

Because this is a prescription medicine taken over months, regular clinical review matters throughout, not just at the start. Our clinical team includes GPhC-registered Independent Prescribers who review every consultation personally; the duration of tirzepatide's action page covers how long each weekly dose stays active in the body. If you'd like to understand the broader context of how Mounjaro sits within weight management options, the weight-loss treatment overview is a useful next step. When you're ready to speak to a prescriber, you can start your free consultation at any point.